Second-generation TKIs Dasatinib, nilotinib, ponatinib, and bosutinib are second-generation TKIs that are used for treatment of Ph+CML
The exact frequency will depend on how your body responds to the treatment and the underlying cause of your deficiency
As stated by the authors of a 2019 review on BPC-157 and soft-tissue healing, Future studies should focus on elucidating as to whether the reported benefits of BPC-157 extend beyond research animals.9 Also, there are some side effects associated with the peptide
Common reasons include: Pernicious anemia , an autoimmune condition affecting intrinsic factor production Gastrointestinal disorders, such as Crohns disease or celiac disease Prolonged use of certain medications, like proton pump inhibitors Knowing these causes helps spot at-risk people
Liver Issues Those who suffer from liver disorders are often unable to store B12
It helps keep nerve fibers covered